Breaking Finance News

AFLAC (NYSE:AFL) target price raised to $73.00, issued a report today by Barclays

Yesterday AFLAC (NYSE:AFL) traded -0.06% lower at $78.42. The company’s 50-day moving average is $79.19 and its 200-day moving average is $75.12. The last closing price is up 6.66% from the 200-day moving average, compared to the S&P 500 which has increased 0.05% over the same time. 454,724 shares of the stock were exchanged, down from an average trading volume of 1,526,670

AFLAC (NYSE:AFL) had its target price raised to $73.00 by Barclays in a report released 7/4/2017. The new target price indicates a possible downside of -0.07% based on the company's last closing price.

Previously on 7/03/2017, Barclays Capital reported on AFLAC (NYSE:AFL) raised the target price from $71.00 to $73.00. At the time, this indicated a possible downside of -0.07%.

See Chart Below

AFLAC (NYSE:AFL)

AFLAC has a 52 week low of $66.50 and a 52 week high of $81.89 with a P/E ratio of 12.11 The company’s market cap is currently $0.

In addition to Barclays reporting its target price, a total of 12 brokers have issued a report on the stock. The consensus target price is $70.92 with 2 brokers rating the stock a strong buy, 1 broker rating the stock a buy, 13 brokers rating the stock a hold, 1 broker rating the stock a underperform, and finally 0 brokers rating the stock a sell.

General Information About AFLAC (NYSE:AFL)

Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.